# EDETATE CALCIUM DISODIUM

URL: https://app.greenveil.ai/ingredients/ingredient_unii_25_ih6_r4_sgf
Categories: pharma
Identifier: cfr:21 CFR 172.120

> EDETATE CALCIUM DISODIUM. Route: INFILTRATION; Dosage form: INJECTION, SOLUTION; Potency: 0.01 %w/v Assessed from 30 sources.

## Safety assessment

- Chemical concern: not yet assessed
- Rationale: Route: INFILTRATION; Dosage form: INJECTION, SOLUTION; Potency: 0.01 %w/v

## Regulatory status

- US: inactive ingredient database — Route: INFILTRATION; Dosage form: INJECTION, SOLUTION; Potency: 0.01 %w/v
- US: inactive ingredient database — Route: INTRA-ARTERIAL; Dosage form: INJECTION; Maximum daily exposure: 25 mg
- US: inactive ingredient database — Route: INTRA-ARTERIAL; Dosage form: INJECTION, SOLUTION; Maximum daily exposure: 25 mg
- US: inactive ingredient database — Route: INTRAMUSCULAR; Dosage form: INJECTION; Potency: 0.05 %w/v
- US: inactive ingredient database — Route: INTRATHECAL; Dosage form: INJECTION; Potency: 2.16 mg
- US: inactive ingredient database — Route: INTRAVASCULAR; Dosage form: INJECTION; Potency: 100 mg
- US: inactive ingredient database — Route: INTRAVASCULAR; Dosage form: INJECTION, SOLUTION; Maximum daily exposure: 108 mg
- US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION; Maximum daily exposure: 25 mg
- US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION, SOLUTION; Maximum daily exposure: 108 mg
- US: inactive ingredient database — Route: INTRAVESICAL; Dosage form: SOLUTION; Potency: 0.11 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE; Potency: NA
- US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE, EXTENDED RELEASE; Potency: NA
- US: inactive ingredient database — Route: ORAL; Dosage form: CONCENTRATE; Potency: 0.25 mg/1ml
- US: inactive ingredient database — Route: ORAL; Dosage form: DROPS; Potency: NA
- US: inactive ingredient database — Route: ORAL; Dosage form: ELIXIR; Potency: 5 mg/5ml
- US: inactive ingredient database — Route: ORAL; Dosage form: POWDER, FOR SOLUTION; Potency: 0.22 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: POWDER, FOR SUSPENSION; Potency: NA
- US: inactive ingredient database — Route: ORAL; Dosage form: SUSPENSION; Potency: NA
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET; Maximum daily exposure: 4 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, FILM COATED; Potency: 0.4 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, ORALLY DISINTEGRATING; Potency: 0.78 mg
- US: inactive ingredient database — Route: SUBCUTANEOUS; Dosage form: INJECTION; Potency: 5 mg
- US: inactive ingredient database — Route: SUBCUTANEOUS; Dosage form: INJECTION, SOLUTION; Potency: 0.06 %w/v
- US: inactive ingredient database — Route: TOPICAL; Dosage form: OINTMENT; Maximum daily exposure: 2 mg
- US: inactive ingredient database — Route: TOPICAL; Dosage form: SOLUTION; Potency: 0.01 %w/v
- US: inactive ingredient database — Route: URETHRAL; Dosage form: SOLUTION; Potency: 0.01 %w/v
- US: marketed drug occurrence — FDA NDC lists this ingredient in 1 active drug products and 1 total products.
- US: listed in openFDA substance — openFDA substance registry classifies this ingredient as chemical.

_Assessed by Greenveil._